HHLA2 and metastatic malignant neoplasm in the lymph nodes: Notably, high levels of the HHLA2 protein correlate with increased tumor size and stage, lymph node metastasis and lower rates of relapse-free and overall survival in affected patients (Kula et al. 2024).